Kangmei Pharma | 600518 - Ordinary Share Capital



Kangmei Pharma reported CNY13.86B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2K 0 Dec/2024
Cspc Pharmaceutical CNY 11.03B 26.91M Dec/2024
Dianthus Therapeutics USD 32.18M 32.15M Jun/2025
Genomma Lab Internacional MXN 978.1M 2.6M Jun/2025
Hypermarcas BRL 632.94M 1.14M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
IQVIA Holdings USD 170M 167.42M Jun/2025
Jiangsu Hengrui CNY 6.64B 258.2M Jun/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Moderna USD 389M 388.96M Jun/2025
Organon & Co USD 259.96M 256.96M Jun/2025
Revvity USD 117.87M 2.78M Jun/2025
Sh Fosun Pharma CNY 2.67B 897.14K Jun/2025
Tectonic Therapeutic USD 18.71M 18.71M Jun/2025
Viatris USD 1.17B 1.15B Jun/2025
Wuxi Apptec CNY 2.87B 15.78M Jun/2025
Xeris Pharmaceuticals USD 161.22M 161.21M Jun/2025
Zz Pientze Pharmaceu 603.32M 0 Jun/2025